甲状腺功能检查异常和甲状腺自身免疫与早产的关系:系统综述与荟萃分析
该系统综述与荟萃分析纳入19个队列共47045名孕妇,评估亚临床甲状腺功能减退、孤立性低甲状腺素血症和甲状腺过氧化物酶抗体阳性与早产的关系。结果显示,上述三种情况均与早产风险升高显著相关,亚临床甲状腺功能减退者早产率为6.1%,孤立性低甲状腺素血症者为7.1%,甲状腺过氧化物酶抗体阳性者为6.6%,均高于甲状腺功能正常者的5.0%。
要点
- 亚临床甲状腺功能减退孕妇早产风险高于甲状腺功能正常者(6.1% vs 5.0%,OR 1.29)。
- 孤立性低甲状腺素血症孕妇早产风险高于甲状腺功能正常者(7.1% vs 5.0%,OR 1.46)。
- 甲状腺过氧化物酶抗体阳性孕妇早产风险高于抗体阴性者(6.6% vs 4.9%,OR 1.33)。
核心结论
- 在无显性甲状腺疾病的孕妇中,亚临床甲状腺功能减退、孤立性低甲状腺素血症和甲状腺过氧化物酶抗体阳性与早产风险升高显著相关。
研究设计与样本
- 系统综述与荟萃分析,检索Ovid MEDLINE、EMBASE、Web of Science、Cochrane Central Register of Controlled Trials和Google Scholar数据库自建库至2018年3月18日的文献,并纳入已发表和未发表的前瞻性队列研究个体参与者数据。
- 共纳入19个队列,包括47045名孕妇(平均年龄29岁,采血时中位孕周12.9周)。
主要发现
- 亚临床甲状腺功能减退孕妇早产风险高于甲状腺功能正常孕妇(6.1% vs 5.0%;绝对风险差1.4% [95% CI, 0%-3.2%];OR 1.29 [95% CI, 1.01-1.64])。
- 孤立性低甲状腺素血症孕妇早产风险高于甲状腺功能正常孕妇(7.1% vs 5.0%;绝对风险差2.3% [95% CI, 0.6%-4.5%];OR 1.46 [95% CI, 1.12-1.90])。
- 甲状腺过氧化物酶抗体阳性孕妇早产风险高于抗体阴性孕妇(6.6% vs 4.9%;绝对风险差1.6% [95% CI, 0.7%-2.8%];OR 1.33 [95% CI, 1.15-1.56])。
- 连续分析中,母亲促甲状腺激素浓度每升高1个标准差,早产风险升高(每1个标准差绝对风险差0.2% [95% CI, 0%-0.4%];OR 1.04 [95% CI, 1.00-1.09])。
临床怎么用
- 原文指出,这些结果有助于优化临床决策策略,该策略应考虑筛查项目及妊娠期左甲状腺素治疗的潜在获益与风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Maternal hypothyroidism and hyperthyroidism are risk factors for preterm birth. Milder thyroid function test abnormalities and thyroid autoimmunity are more prevalent, but it remains controversial if these are associated with preterm birth. OBJECTIVE: To study if maternal thyroid function test abnormalities and thyroid autoimmunity are risk factors for preterm birth. DATA SOURCES AND STUDY SELECTION: Studies were identified through a search of the Ovid MEDLINE, EMBASE, Web of Science, the Cochrane Central Register of Controlled Trials, and Google Scholar databases from inception to March 18, 2018, and by publishing open invitations in relevant journals. Data sets from published and unpublished prospective cohort studies with data on thyroid function tests (thyrotropin [often referred to as thyroid-stimulating hormone or TSH] and free thyroxine [FT4] concentrations) or thyroid peroxidase (TPO) antibody measurements and gestational age at birth were screened for eligibility by 2 independent reviewers. Studies in which participants received treatment based on abnormal thyroid function tests were excluded. DATA EXTRACTION AND SYNTHESIS: The primary authors provided individual participant data that were analyzed using mixed-effects models. MAIN OUTCOMES AND MEASURES: The primary outcome was preterm birth (<37 weeks' gestational age). RESULTS: From 2526 published reports, 35 cohorts were invited to participate. After the addition of 5 unpublished data sets, a total of 19 cohorts were included. The study population included 47 045 pregnant women (mean age, 29 years; median gestational age at blood sampling, 12.9 weeks), of whom 1234 (3.1%) had subclinical hypothyroidism (increased thyrotropin concentration with normal FT4 concentration), 904 (2.2%) had isolated hypothyroxinemia (decreased FT4 concentration with normal thyrotropin concentration), and 3043 (7.5%) were TPO antibody positive; 2357 (5.0%) had a preterm birth. The risk of preterm birth was higher for women with subclinical hypothyroidism than euthyroid women (6.1% vs 5.0%, respectively; absolute risk difference, 1.4% [95% CI, 0%-3.2%]; odds ratio [OR], 1.29 [95% CI, 1.01-1.64]). Among women with isolated hypothyroxinemia, the risk of preterm birth was 7.1% vs 5.0% in euthyroid women (absolute risk difference, 2.3% [95% CI, 0.6%-4.5%]; OR, 1.46 [95% CI, 1.12-1.90]). In continuous analyses, each 1-SD higher maternal thyrotropin concentration was associated with a higher risk of preterm birth (absolute risk difference, 0.2% [95% CI, 0%-0.4%] per 1 SD; OR, 1.04 [95% CI, 1.00-1.09] per 1 SD). Thyroid peroxidase antibody-positive women had a higher risk of preterm birth vs TPO antibody-negative women (6.6% vs 4.9%, respectively; absolute risk difference, 1.6% [95% CI, 0.7%-2.8%]; OR, 1.33 [95% CI, 1.15-1.56]). CONCLUSIONS AND RELEVANCE: Among pregnant women without overt thyroid disease, subclinical hypothyroidism, isolated hypothyroxinemia, and TPO antibody positivity were significantly associated with higher risk of preterm birth. These results provide insights toward optimizing clinical decision-making strategies that should consider the potential harms and benefits of screening programs and levothyroxine treatment during pregnancy.
引用
- Korevaar TIM, Derakhshan A, Taylor PN, et al. Association of Thyroid Function Test Abnormalities and Thyroid Autoimmunity With Preterm Birth: A Systematic Review and Meta-analysis. JAMA. 2019. PMID: 31429897. doi:10.1001/jama.2019.10931
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。